• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于食物偏好的筛选方法,利用秀丽隐杆线虫鉴定物质使用障碍的效应因子。

Food preference-based screening method for identification of effectors of substance use disorders using Caenorhabditis elegans.

机构信息

Department of Food Science, University of Massachusetts, Amherst, MA 01003, USA.

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

出版信息

Life Sci. 2024 May 15;345:122580. doi: 10.1016/j.lfs.2024.122580. Epub 2024 Mar 19.

DOI:10.1016/j.lfs.2024.122580
PMID:38514005
Abstract

Substance use disorder (SUD) affects over 48 million Americans aged 12 and over. Thus, identifying novel chemicals contributing to SUD will be critical for developing efficient prevention and mitigation strategies. Considering the complexity of the actions and effects of these substances on human behavior, a high-throughput platform using a living organism is ideal. We developed a quick and easy screening assay using Caenorhabditis elegans. C. elegans prefers high-quality food (Escherichia coli HB101) over low-quality food (Bacillus megaterium), with a food preference index of approximately 0.2, defined as the difference in the number of worms at E. coli HB101 and B. megaterium over the total worm number. The food preference index was significantly increased by loperamide, a μ-opioid receptor (MOPR) agonist, and decreased by naloxone, a MOPR antagonist. These changes depended on npr-17, a C. elegans homolog of opioid receptors. In addition, the food preference index was significantly increased by arachidonyl-2'-chloroethylamide, a cannabinoid 1 receptor (CB1R) agonist, and decreased by rimonabant, a CB1R inverse agonist. These changes depended on npr-19, a homolog of CB1R. These results suggest that the conserved opioid and endocannabinoid systems modulate the food preference behaviors of C. elegans. Finally, the humanoid C. elegans strains where npr-17 was replaced with human MOPR and where npr-19 was replaced with human CB1R phenocopied the changes in food preference by the drug treatment. Together, the current results show that this method can be used to rapidly screen the potential effectors of MOPR and CB1R to yield results highly translatable to humans.

摘要

物质使用障碍(SUD)影响着超过 4800 万 12 岁及以上的美国人。因此,鉴定导致 SUD 的新型化学物质对于开发有效的预防和缓解策略至关重要。考虑到这些物质对人类行为的作用和影响的复杂性,使用活体生物的高通量平台是理想的。我们使用秀丽隐杆线虫(C. elegans)开发了一种快速简便的筛选测定法。秀丽隐杆线虫更喜欢高质量的食物(大肠杆菌 HB101)而不是低质量的食物(巨大芽孢杆菌),食物偏好指数约为 0.2,定义为大肠杆菌 HB101 和巨大芽孢杆菌的线虫数量与总线虫数量之差。洛哌丁胺(一种 μ-阿片受体(MOPR)激动剂)显著增加了食物偏好指数,纳洛酮(一种 MOPR 拮抗剂)则降低了食物偏好指数。这些变化取决于秀丽隐杆线虫阿片受体的同源物 npr-17。此外,花生四烯酰-2'-氯乙酰胺(一种大麻素 1 型受体(CB1R)激动剂)显著增加了食物偏好指数,利莫那班(一种 CB1R 反向激动剂)则降低了食物偏好指数。这些变化取决于 CB1R 的同源物 npr-19。这些结果表明,保守的阿片类和内源性大麻素系统调节秀丽隐杆线虫的食物偏好行为。最后,将 npr-17 替换为人 MOPR 的类人秀丽隐杆线虫菌株和将 npr-19 替换为人 CB1R 的类人秀丽隐杆线虫菌株复制了药物处理引起的食物偏好变化。总之,目前的结果表明,该方法可用于快速筛选 MOPR 和 CB1R 的潜在效应物,从而获得高度可转化为人类的结果。

相似文献

1
Food preference-based screening method for identification of effectors of substance use disorders using Caenorhabditis elegans.基于食物偏好的筛选方法,利用秀丽隐杆线虫鉴定物质使用障碍的效应因子。
Life Sci. 2024 May 15;345:122580. doi: 10.1016/j.lfs.2024.122580. Epub 2024 Mar 19.
2
Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders.秀丽隐杆线虫作为一种模型系统,用于鉴定治疗酒精使用障碍的药物。
Behav Brain Res. 2019 Jun 3;365:7-16. doi: 10.1016/j.bbr.2019.02.015. Epub 2019 Feb 22.
3
Caenorhabditis Elegans Exhibits Morphine Addiction-like Behavior via the Opioid-like Receptor NPR-17.秀丽隐杆线虫通过类阿片受体NPR-17表现出类似吗啡成瘾的行为。
Front Pharmacol. 2022 Jan 3;12:802701. doi: 10.3389/fphar.2021.802701. eCollection 2021.
4
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.与对强迫性奖赏相关行为有不同影响的其他配体相比,GSK1521498的阿片受体药理学。
Psychopharmacology (Berl). 2015 Jan;232(1):305-14. doi: 10.1007/s00213-014-3666-3. Epub 2014 Jun 29.
5
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.AM-251 和利莫那班作为μ-阿片受体的直接拮抗剂:对阿片类药物/大麻素相互作用研究的影响。
Neuropharmacology. 2012 Oct;63(5):905-15. doi: 10.1016/j.neuropharm.2012.06.046. Epub 2012 Jul 4.
6
Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice.大麻素 1 型受体和μ 阿片受体激动剂协同抑制小鼠腹痛且无副作用。
J Neurosci. 2022 Aug 17;42(33):6313-6324. doi: 10.1523/JNEUROSCI.0641-22.2022. Epub 2022 Jul 5.
7
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.大麻素受体配体作为物质使用障碍治疗的潜力。
CNS Drugs. 2019 Oct;33(10):1001-1030. doi: 10.1007/s40263-019-00664-w.
8
daf-16/FOXO isoform b in AIY neurons is involved in low preference for Bifidobacterium infantis in Caenorhabditis elegans.AIY 神经元中的 daf-16/FOXO 同种型 b 参与秀丽隐杆线虫对双歧杆菌婴儿亚种的低偏好。
Neurosci Res. 2020 Jan;150:8-16. doi: 10.1016/j.neures.2019.01.011. Epub 2019 Feb 4.
9
Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.新型双功能孤啡肽受体/μ-阿片受体配体的抗伤害感受和抗奖赏特性比较:对治疗应用的启示
J Pharmacol Exp Ther. 2009 Dec;331(3):954-64. doi: 10.1124/jpet.109.157446. Epub 2009 Sep 22.
10
An opioid-like system regulating feeding behavior in C. elegans.一种调节秀丽隐杆线虫进食行为的阿片样系统。
Elife. 2015 Apr 21;4:e06683. doi: 10.7554/eLife.06683.

引用本文的文献

1
Strain-specific effects of Desulfovibrio on neurodegeneration and oxidative stress in a Caenorhabditis elegans PD model.脱硫弧菌对秀丽隐杆线虫帕金森病模型中神经退行性变和氧化应激的菌株特异性影响。
NPJ Parkinsons Dis. 2025 Aug 11;11(1):236. doi: 10.1038/s41531-025-01102-z.
2
Esculetin Inhibits Fat Accumulation Through Insulin/Insulin-like Growth Factor- and AMP-Activated Protein Kinase-Dependent Pathways in .七叶亭通过胰岛素/胰岛素样生长因子和AMP激活的蛋白激酶依赖性途径抑制脂肪积累 。 (你提供的原文似乎不完整,句末缺少具体的研究对象等内容)
Nutrients. 2025 May 1;17(9):1565. doi: 10.3390/nu17091565.